Clinical Trials Browser

Colorectal Neoplasms × Injections × 90 days × Clear all

NCT07621497 2026-06-02

FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)

Phase 2 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms